$29.73
0.220.75%
Last update: Oct 9, 4:00 PM
$29.62
0.110.37%
Lakefront Biotherapeutics NV
LKFTNASDAQ
Lakefront Biotherapeutics (LKFT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-13.52 | $-1.27 | $1.00 | $-0.36 |
| Actual | $0.29 | $0.25 | $13.82 | $-3.59 |
| Surprise | +102.1% | +119.7% | +1281.8% | -897.2% |
| Revenue | ||||
| Estimate | $7.2M | $16.0M | $83.8M | $83.6M |
| Actual | $21.6M | $7.6M | $1.05B | $83.2M |
| Surprise | +199.9% | -52.7% | +1151.6% | -0.51% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.31 | $-0.81 | $-0.49 | $-0.50 |
| Revenue | ||||
| Consensus | $8.7M | $8.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $0.29 | $-13.52 | 102.1 % |
| Q1 | May 6, 2026 | $0.25 | $-1.27 | 119.7 % |
| Q4 | Feb 23, 2026 | $13.82 | $1.00 | 1281.8 % |
| Q3 | Nov 5, 2025 | $-3.59 | $-0.36 | -897.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $21.62M | $7.21M | 199.9 % |
| Q1 | May 6, 2026 | $7.59M | $16.04M | -52.7 % |
| Q4 | Feb 23, 2026 | $1.05B | $83.81M | 1151.6 % |
| Q3 | Nov 5, 2025 | $83.20M | $83.63M | -0.51 % |
